Mibenratide Uses, Dosage, Side Effects and more

Mibenratide is under investigation in clinical trial NCT01798745 (A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies).

Trade Name Mibenratide
Generic Mibenratide
Mibenratide Other Names JNJ-54452840, Mibenratide
Type
Formula C87H129N27O30S2
Weight Average: 2097.27
Monoisotopic: 2095.88400821
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share